NCT01001572 - Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension | Biotech Hunter

Enrollment

932

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Essential Hypertension

Interventions

DRUG

Valsartan/amlodipine 160/5 mg

Valsartan/amlodipine 160/5mg film coated tablets taken orally once daily.

DRUG

Valsartan 160 mg

Valsartan 160 mg capsule taken orally once daily.

DRUG

Placebo

1 capsule or tablet taken orally once daily

Trial Locations (2)

Investigative site in Romainia

Novartis Investigative Site